- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1423-0127
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Antivirals blocking entry of enteroviruses and therapeutic potential ; volume:28 ; number:1 ; day:15 ; month:1 ; year:2021 ; pages:1-12 ; date:12.2021
Journal of biomedical science ; 28, Heft 1 (15.1.2021), 1-12, 12.2021
- Urheber
-
Anasir, Mohd Ishtiaq
Zarif, Faisal
Poh, Chit Laa
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12929-021-00708-8
- URN
-
urn:nbn:de:101:1-2021030610552679981443
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Anasir, Mohd Ishtiaq
- Zarif, Faisal
- Poh, Chit Laa
- SpringerLink (Online service)
Ähnliche Objekte (12)
Alkaloids as potential antivirals. A comprehensive review
Potential for the Repurposing of Adamantane Antivirals for COVID-19
Arbovirosis and potential transmission blocking vaccines
Limit Pricing, Potential Entry and Barriers to Entry
Macromolecular viral entry inhibitors as broad-spectrum first-line antivirals with activity against SARS-CoV-2
Macromolecular Viral Entry Inhibitors as Broad‐Spectrum First‐Line Antivirals with Activity against SARS‐CoV‐2
SELEX based aptamers with diagnostic and entry inhibitor therapeutic potential for SARS-CoV-2
Analysis of synthetic compounds and natural extracts as potential antivirals against human Noroviruses
Antivirals and vaccines for Enterovirus A71
Development and characterization of formulations based on combinatorial potential of antivirals against genital herpes
Evaluation of the therapeutic regimen in COVID-19 in transplant patients: where do immunomodulatory and antivirals stand?
R5X4 HIV-1 coreceptor use in primary target cells: implications for coreceptor entry blocking strategies
Alkaloids as potential antivirals. A comprehensive review
Potential for the Repurposing of Adamantane Antivirals for COVID-19
Arbovirosis and potential transmission blocking vaccines
Limit Pricing, Potential Entry and Barriers to Entry
Macromolecular viral entry inhibitors as broad-spectrum first-line antivirals with activity against SARS-CoV-2
Macromolecular Viral Entry Inhibitors as Broad‐Spectrum First‐Line Antivirals with Activity against SARS‐CoV‐2
SELEX based aptamers with diagnostic and entry inhibitor therapeutic potential for SARS-CoV-2
Analysis of synthetic compounds and natural extracts as potential antivirals against human Noroviruses
Antivirals and vaccines for Enterovirus A71
Development and characterization of formulations based on combinatorial potential of antivirals against genital herpes
Evaluation of the therapeutic regimen in COVID-19 in transplant patients: where do immunomodulatory and antivirals stand?
R5X4 HIV-1 coreceptor use in primary target cells: implications for coreceptor entry blocking strategies
Alkaloids as potential antivirals. A comprehensive review
Potential for the Repurposing of Adamantane Antivirals for COVID-19
Arbovirosis and potential transmission blocking vaccines
Limit Pricing, Potential Entry and Barriers to Entry
Macromolecular viral entry inhibitors as broad-spectrum first-line antivirals with activity against SARS-CoV-2
Macromolecular Viral Entry Inhibitors as Broad‐Spectrum First‐Line Antivirals with Activity against SARS‐CoV‐2
SELEX based aptamers with diagnostic and entry inhibitor therapeutic potential for SARS-CoV-2
Analysis of synthetic compounds and natural extracts as potential antivirals against human Noroviruses
Antivirals and vaccines for Enterovirus A71
Development and characterization of formulations based on combinatorial potential of antivirals against genital herpes
Evaluation of the therapeutic regimen in COVID-19 in transplant patients: where do immunomodulatory and antivirals stand?